Bivatuzumab BIWA 4: A New Medical Candidate Bivatuzumab BIWA 4 is a novel medicinal candidate for treating specific malignancies. This molecule selectively targets a critical molecule involved in malignant development https://bivatuzumab600835.aboutyoublog.com/54583126/text